Preclinical evaluation of coronary stents: focus on safety issues

A Perez de Prado, C Pérez-Martínez… - Current Vascular …, 2013 - benthamdirect.com
In recent years, we have witnessed a revolution in the treatment of coronary artery disease.
The development and improvement of drug eluting stents (DES) have lowered the incidence …

Hemodialysis catheter thrombi: visualization and quantification of microstructures and cellular composition

TC Lucas, F Tessarolo, P Veniero… - The Journal of …, 2013 - journals.sagepub.com
Purpose Despite the increasing use of central venous catheters (CVC) for hemodialysis in
clinical practice, the role of CVC in thrombus development is poorly understood. This work …

[HTML][HTML] Camouflaging endovascular stents with an endothelial coat using CD31 domain 1 and 2 mimetic peptides

J Sénémaud, C Skarbek, B Hernandez, R Song… - JVS-Vascular …, 2024 - Elsevier
Objective Implantation of an endovascular device disrupts the homeostatic CD31: CD31
interactions among quiescent endothelial cells (ECs), platelets, and circulating leukocytes …

Effects of ultraviolet irradiation on bonding strength between Co–Cr alloy and citric acid-crosslinked gelatin matrix

M Inoue, M Sasaki, Y Katada… - Journal of biomaterials …, 2014 - journals.sagepub.com
Novel techniques for creating a strong bond between polymeric matrices and biometals are
required. We immobilized polymeric matrices on the surface of biometal for drug-eluting …

Seguridad y eficacia de nuevos modelos de stents liberadores de sirolimus con polímero biodegradable en el modelo preclínico

AP de Prado, CP Martínez, CC Ramón… - Revista Española de …, 2017 - Elsevier
Introducción y objetivos Los nuevos stents farmacoactivos (SFA), diseñados para solventar
las limitaciones de los existentes, han de someterse inicialmente al análisis preclínico. El …

Safety and Efficacy of New Biodegradable Polymer-based Sirolimus-Eluting Stents in a Preclinical Model

AP de Prado, CP Martínez, CC Ramón… - Revista Española de …, 2017 - Elsevier
Introduction and objectives New drug-eluting stents (DES) designed to overcome the
limitations of existing devices should initially be tested in preclinical studies. Our objective …

Cambios estructurales y funcionales de las arterias coronarias tratadas con plataformas coronarias bioabsorbibles Absorb BVS

LR Goncalves Ramírez - 2021 - uvadoc.uva.es
I-1.1-INTRODUCCIÓN: La reabsorción completa de los dispositivos Absorb BVS (Abbott
Vascular, USA), así como la recuperación estructural y funcional de las arterias coronarias …

[PDF][PDF] Vasomotor response to different endothelium-dependent vasodilators in an animal model

AP de Prado, C Cuellas, A Diego… - J INVASIVE …, 2012 - academia.edu
Background and Objectives. Incomplete re-endothelialization of stents can be revealed as
paradoxical vasoconstriction with endothelium-dependent vasodilators. As no consensus …

Microscopio Electrónico de Barrido para Evaluar los Cambios Morfológicos y Microquímicos.

V Orlando, P Hernández, P Herrera… - Acta …, 2019 - search.ebscohost.com
English Scanning Electron Microscopy provides a description of the physics of electron-
probe formation and of electron-specimen interactions. A scanning electron microscope …

Biocompatibility improvement conferred by the immobilization of a CD31 peptide on endovascular stents

C Rasser - 2017 - theses.hal.science
Over the last decades, coronary stents and intracranial flow diverting stents have
revolutionized the endovascular treatment of two different arterial pathologies: coronary …